Contents

Search


ulcerative proctitis

see Proctitis Pathology: - rectal mucosa may show - loss of vascular markings - erythema - friability - chronic inflammation - crypt distortion, crypt atrophy Clinical manifestations: - diarrhea - tenesmus - fecal urgency - rectal bleeding Complications: - little if any increased risk of colon cancer if inflammation is confined to rectum (contrast with ulcerative colitis) Management: - colon cancer screening per schedule without risk factors - glucocorticoid rectal foam - budesonide rectal foam - 2 mg per 25 mL twice daily for 2 weeks, then once daily for 4 weeks [2] - hydrocortisone rectal foam - sulfasalazine - folate supplementation with sulfasalazine - sulfasalazine inhibits folate absorption [3]

Related

ulcerative colitis (UC)

General

proctitis (rectitis)

References

  1. Medical Knowledge Self Assessment Program (MKSAP) 16 American College of Physicians, Philadelphia 2012
  2. Sandborn WJ et al. Budesonide foam induces remission in patients with mild to moderate ulcerative proctitis and ulcerative proctosigmoiditis. Gastroenterology 2015 Jan 30 PMID: 25644096 http://www.gastrojournal.org/article/S0016-5085%2815%2900154-7/abstract
  3. NEJM Knowledge+ Gastroenterology